A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction

被引：0
|
作者：
Kei Hosoda
Mizutomo Azuma
Chikatoshi Katada
Kenji Ishido
Masahiro Niihara
Hideki Ushiku
Mikiko Sakuraya
Marie Washio
Takuya Wada
Akinori Watanabe
Hiroki Harada
Satoshi Tanabe
Wasaburo Koizumi
Keishi Yamashita
Naoki Hiki
机构：
[1] Kitasato University School of Medicine,Department of Upper Gastrointestinal Surgery
[2] Kitasato University School of Medicine,Department of Gastroenterology
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Locally advanced esophagogastric junction cancer; Docetaxel; Oxaliplatin; S-1; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1090 / 1097
页数：7
相关论文
共 50 条
  • [41] Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy
    Feng, Daofu
    Leong, Meiha
    Li, Ting
    Chen, Lin
    Li, Tao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [42] Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
    Kosaka, Takashi
    Akiyama, Hirotoshi
    Miyamoto, Hiroshi
    Sato, Sho
    Tanaka, Yusaku
    Sato, Kei
    Kunisaki, Chikara
    Endo, Itaru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (06) : 1047 - 1055
  • [43] Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
    Takashi Kosaka
    Hirotoshi Akiyama
    Hiroshi Miyamoto
    Sho Sato
    Yusaku Tanaka
    Kei Sato
    Chikara Kunisaki
    Itaru Endo
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 1047 - 1055
  • [44] Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy
    Daofu Feng
    Meiha Leong
    Ting Li
    Lin Chen
    Tao Li
    World Journal of Surgical Oncology, 13
  • [45] Phase II trial of S-1 combined with oxaliplatin (SOX) as neoadjuvant chemotherapy for locally advanced gastric cancer
    Chen, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [46] Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS) as first-line therapy in patients with advanced gastro-esophageal cancer
    Vestermark, L.
    Jensen, H.
    Schoennemann, K.
    Krogh, M.
    Pfeiffer, P.
    ANNALS OF ONCOLOGY, 2015, 26
  • [47] A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer
    Sakamoto, Yoshiyuki
    Morohashi, Hajime
    Miura, Takuya
    Tsutsumi, Shinji
    Takahashi, Seiji
    Hirama, Kimiaki
    Wakiya, Taiichi
    Hakamada, Kenichi
    DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 663 - 671
  • [48] PHASE II STUDY OF COMBINATION CHEMOTHERAPY WITH ORAL S-1 AND OXALIPLATIN (SOX) IN PATIENTS WITH MUCINOUS ADENOCARCINOMA OF THE OVARY
    Nishio, S.
    Shimada, M.
    Kamura, T.
    Ishitani, K.
    Ochiai, K.
    Takeshima, N.
    Yokoyama, Y.
    Furumoto, H.
    Sugiyama, T.
    Kigawa, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 326 - 326
  • [49] Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer
    Kang, Yoon-Koo
    Kim, Hyung-Don
    Cho, Hyungwoo
    Park, Young Soo
    Lee, Jong Seok
    Ryu, Min-Hee
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [50] Comparison of Docetaxel plus Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis
    Zhang, Xin
    Huang, Hejing
    Wei, Ziran
    Zhu, Zhenxin
    Yang, Dejun
    Fu, Hongbing
    Xu, Jiapeng
    Hu, Zunqi
    Zhang, Yu
    You, Qing
    Huang, Xin
    Yan, Ronglin
    Wang, Weimin
    Cai, Qingping
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 6641 - 6653
12345